Követés
Akash Chaurasiya
Akash Chaurasiya
Assistant Professor, BITS PILANI HYDERABAD CAMPUS, INDIA
E-mail megerősítve itt: hyderabad.bits-pilani.ac.in
Cím
Hivatkozott rá
Hivatkozott rá
Év
Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS)
AK Singh, A Chaurasiya, A Awasthi, G Mishra, D Asati, RK Khar, ...
Aaps Pharmscitech 10, 906-916, 2009
2002009
Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization
AK Singh, A Chaurasiya, M Singh, SC Upadhyay, R Mukherjee, RK Khar
Aaps Pharmscitech 9, 628-634, 2008
1462008
Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting
SK Jain, A Chaurasiya, Y Gupta, A Jain, P Dagur, B Joshi, VM Katoch
Journal of microencapsulation 25 (5), 289-297, 2008
842008
Polysaccharide-based nanofibers for pharmaceutical and biomedical applications: A review
S Priya, U Batra, RN Samshritha, S Sharma, A Chaurasiya, G Singhvi
International Journal of Biological Macromolecules 218, 209-224, 2022
662022
Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B
C Maheshwari, RS Pandey, A Chaurasiya, A Kumar, DT Selvam, ...
International immunopharmacology 11 (10), 1516-1522, 2011
512011
Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics
RM Kumar, H Kumar, T Bhatt, R Jain, K Panchal, A Chaurasiya, V Jain
Pharmaceuticals 16 (2), 196, 2023
492023
A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges
A Chaurasiya, A Gorajiya, K Panchal, S Katke, AK Singh
Drug delivery and translational research, 1-19, 2022
432022
Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
K Panchal, RK Sahoo, U Gupta, A Chaurasiya
International immunopharmacology 95, 107508, 2021
362021
RETRACTED ARTICLE: Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes
A Chaurasiya, AK Singh, GK Jain, MH Warsi, E Sublet, FJ Ahmad, ...
Journal of microencapsulation 29 (6), 583-595, 2012
292012
High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats
AK Singh, A Chaurasiya, GK Jain, A Awasthi, D Asati, G Mishra, RK Khar, ...
Talanta 78 (4-5), 1310-1314, 2009
282009
An expanding horizon of complex injectable products: development and regulatory considerations
K Panchal, S Katke, SK Dash, A Gaur, A Shinde, N Saha, NK Mehra, ...
Drug delivery and translational research 13 (2), 433-472, 2023
232023
Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies
E Pardhi, R Yadav, A Chaurasiya, J Madan, SK Guru, SB Singh, ...
Life Sciences 325, 121771, 2023
142023
Biologics: Delivery options and formulation strategies
R Nongkhlaw, P Patra, A Chavrasiya, N Jayabalan, S Dubey
Drug Delivery Aspects, 115-155, 2020
122020
Aqueous humor pharmacokinetics of dorzolamide loaded PLGAChitosan nanoparticles by ultra performance liquid chromatography
M H Warsi, A Chaurasiya, G K Jain, S A Pathan, P Chander, A K Singh, ...
Current Pharmaceutical Analysis 7 (3), 189-194, 2011
112011
Development of nanomedicines and nano-similars: Recent advances in regulatory landscape
R Paliwal, P Kumar, A Chaurasiya, R Kenwat, S Katke, SR Paliwal
Current Pharmaceutical Design 28 (2), 165-177, 2022
102022
Lipid-based nanocarriers in the treatment of glioblastoma multiforme (GBM): challenges and opportunities
T Gupta, RK Sahoo, H Singh, S Katke, A Chaurasiya, U Gupta
AAPS PharmSciTech 24 (4), 102, 2023
92023
Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives
A Shinde, K Panchal, S Katke, R Paliwal, A Chaurasiya
Therapies 77 (4), 425-443, 2022
82022
Stable liquid ready-to-use injectable formulation of bortezomib
RA Shaik, A Chaurasiya, S Ananya, BV Patel, H Bhagwatwar, SA Pillai
US Patent App. 15/323,488, 2017
72017
Drug Delivery Aspects
R Nongkhlaw, P Patra, A Chavrasiya, N Jayabalan, S Dubey
Elsevier, 2020
52020
N-2-Hydroxypropylmethacrylamide–Polycaprolactone Polymeric Micelles in Co-delivery of Proteasome Inhibitor and Polyphenol: Exploration of Synergism or …
S Rani, RK Sahoo, V Kumar, A Chaurasiya, O Kulkarni, A Mahale, ...
Molecular Pharmaceutics 20 (1), 524-544, 2022
42022
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20